Fanconi anaemia group C gene therapy

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFanconi anaemia group C gene therapy
Drug Alias NameFanconi's syndrome gene therapyFanconi's anaemia gene therapy
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsFanconi Anemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of Health
Inactive CompaniesN/A
Active IndicationsFanconi Anemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A